- Report
- February 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- February 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- February 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- November 2023
- 146 Pages
Global
From €2407EUR$2,499USD£2,070GBP
- Report
- May 2024
- 292 Pages
Global
From €5393EUR$5,600USD£4,638GBP
- Report
- January 2024
- 146 Pages
Global
From €3755EUR$3,899USD£3,229GBP
- Report
- November 2023
- 150 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- February 2024
- 116 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 114 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- October 2023
- 178 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- October 2023
- 181 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- October 2023
- 178 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- February 2024
- 120 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- November 2023
- 181 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- August 2023
- 145 Pages
Global
From €3033EUR$3,150USD£2,609GBP
- Report
- September 2023
- 155 Pages
Global
From €2408EUR$2,500USD£2,071GBP
- Report
- March 2024
- 249 Pages
Global
€4810EUR$4,995USD£4,137GBP
- Report
- October 2023
- 180 Pages
Global
From €4618EUR$4,795USD£3,971GBP
The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more